Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4'-Ethynyl-2-fluoro-2'-deoxyadenosine).
暂无分享,去创建一个
Min Xu | I. Raheem | M. Lai | J. Meillon | K. Fillgrove | F. Alexandre | Thierry Convard | Houcine Rahali | Rachid Rahali | C. Dousson | J. Small | Sandra Guillon
[1] B. Taiwo,et al. Long-Acting Antiretrovirals: Where Are We now? , 2017, Current HIV/AIDS Reports.
[2] S. Sarafianos,et al. Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) , 2016, Proceedings of the National Academy of Sciences.
[3] S. Peyrottes,et al. Recent Trends in Nucleotide Synthesis. , 2016, Chemical reviews.
[4] C. Lionne,et al. Intracellular Metabolism of Nucleoside/Nucleotide Analogues: a Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase. , 2016, Current drug metabolism.
[5] H. Ohrui. A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-HIV Active EFdA , 2014 .
[6] C. Godfrey,et al. NRTI Backbone in HIV Treatment , 2012, Drugs.
[7] M. Sofia,et al. Synthesis of diastereomerically pure nucleotide phosphoramidates. , 2011, The Journal of organic chemistry.
[8] C. K. Chu,et al. Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity , 2011 .
[9] P. NagaAnusha. Antiretroviral Strategies for Treatment of HIV , 2011 .
[10] Zhen Huang,et al. Convenient synthesis of nucleoside 5'-triphosphates for RNA transcription. , 2011, Chemical communications.
[11] E. De Clercq. A 40-year journey in search of selective antiviral chemotherapy. , 2011, Annual review of pharmacology and toxicology.
[12] S. Sarafianos,et al. Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase , 2010, Viruses.
[13] A. Brancale,et al. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition. , 2009, Journal of medicinal chemistry.
[14] S. Sarafianos,et al. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. , 2009, Journal of molecular biology.
[15] S. Sarafianos,et al. 2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. , 2008, The international journal of biochemistry & cell biology.
[16] S. Weller,et al. A Review of the Pharmacokinetics of Abacavir , 2008, Clinical pharmacokinetics.
[17] Y. Kondo,et al. Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives : Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers , 2007 .
[18] C. K. Chu,et al. Enantiomeric synthesis of carbocyclic d-4′-C-methylribonucleosides as potential antiviral agents , 2006 .
[19] S. Schneller,et al. A practical synthetic route to 4′-alkylaristeromycin derivatives: 4′-methylaristeromycin , 2006 .
[20] B. Day,et al. Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective , 2003, Nature Reviews Drug Discovery.
[21] K. Jacobson,et al. Synthesis of a novel conformationally locked carbocyclic nucleoside ring system. , 2003, Organic letters.
[22] C. Perry,et al. Abacavir , 2000, Drugs.
[23] A. Holý,et al. Synthesis of Carba Analogues of Deoxy-4- C -(hydroxymethyl)pentofuranoses, Intermediates in the Synthesis of Carbocyclic Nucleosides , 1998 .